VVOS · Vivos Therapeutics, Inc. · Executive Compensation
$0.13
0.00 (-1.80%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, we had approximately $1.8 million in cash and cash equivalents, which will not be sufficient to fund operations and strategic objectives over the next twelve months from the date of the issuance of these financial statements. Without additional financing, these factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.61M
Shares
20.12M
Volume · Oct 26
666.34K
Avg daily vol (3M)
14.76M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| R. Kirk Huntsman | Chief Executive Officer | $1,306,906 |
| Bradford Amman | Chief Financial Officer | $705,919 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| R. Kirk Huntsman | Chief Executive Officer | $657,701 |
| Bradford Amman | Chief Financial Officer | $400,040 |
| G. Dave Singh | Chief Medical Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| R. Kirk Huntsman | Chief Executive Officer | $937,850 |
| Bradford Amman | Chief Financial Officer | $492,919 |
| G. Dave Singh | Chief Medical Officer | $77,491 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Bradford Amman | Chief Financial Officer | $1,106,092 |
| R. Kirk Huntsman | Chief Executive Officer | $1,077,149 |
| G. Dave Singh | Former Chief Medical Officer | $447,003 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| R. Kirk Huntsman | Chief Executive Officer | $455,336 |
| G. Dave Singh | Former Chief Medical Officer | $298,507 |
| Bradford Amman | Chief Financial Officer | $268,938 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Bradford Amman | Chief Financial Officer (principal accounting officer) | $297,220 |
| G. Dave Singh | Chief Medical Officer | $294,407 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Roman Franklin | Chief Financial Officer and Principal Financial Officer | Appointed | 2026-08-03 |
| Roman Franklin | Chief Financial Officer | Appointed | 2026-08-03 |
| Bradford Amman | Chief Financial Officer and Secretary | Resigned | 2026-08-03 |
| Gregg C. E. Johnson | independent director of the Board | Appointed | 2026-02-06 |
Leadership
- R. Kirk Huntsman CEO
- Roman Franklin CFO
- Anja Krammer Board Member
- Gregg C. E. Johnson Board Member
- Leonard J. Sokolow Board Member
- Mark F. Lindsay Board Member
- Matthew Thompson Board Member
- Ralph E. Green Board Member